* FOR IMMEDIATE RELEASE *
California TMS Clinics, an affiliate clinic of Los Angeles Therapy Institute Offers Santa Monica Residents Access to Breakthrough Depression Treatment.
Local facility provides NeuroStar® Advanced Therapy, a safe and effective non-drug treatment option for depression sufferers
Santa Monica, CA November 10, 2022 - California TMS Clinics https://www.californiatmsclinics.com announced its new offering of NeuroStar Advanced Therapy for Mental Health, making it one of the first and only psychology practices in Santa Monica to provide NeuroStar TMS treatment in combination with psychotherapy services. To celebrate this new service, California TMS Clinics will host an open house on 11/<23>23>/22 from 10am to 12pm at its office in Santa Monica. The event is free and open to anyone who would like to learn more about NeuroStar and how it works.
Approximately 6.2 million people in the U.S. being treated for depression do not benefit from antidepressant medication. (1,2)
California TMS Clinics’ new service, NeuroStar Advanced Therapy, uses transcranial magnetic stimulation (TMS) to activate areas of the brain that are underactive in depression. The addition of this transformational treatment will provide people with access to a proven, non-drug method of treating Major Depressive Disorder in adult patients when antidepressant medications aren’t successful.
“We noticed a trend of treatment resistant depression in our patients in which they had tried all sorts of medications but did not get the desired effect. As a result, they would resort to using unhealthy and destructive copings to manage symptoms. Thus, we decided to offer an alternative method for anxiety and depression treatment.” – Dr. Soheila Hosseini
Recent published data from NeuroStar’s Outcomes Registry, which is the largest depression registry in the world, reported an 83% response rate for patients. (3)
NeuroStar Advanced Therapy is widely covered by major insurance plans and is available by prescription only. The treatment is typically administered daily for four to six weeks. Unlike electroconvulsive therapy (ECT), NeuroStar Advanced Therapy is non-invasive and allows patients to resume daily activities immediately following treatment sessions. It is also free from systemic side effects often associated with antidepressant medications. (4)
The most common side effect is temporary mild to moderate pain or discomfort at or near the treatment site. NeuroStar is indicated for the treatment of Major Depressive Disorder in adult patients who have failed to receive satisfactory improvement from prior antidepressant medication in the current episode. To learn more, visit www.californiatmsclinics.com, and to schedule an appointment, call 310.857.4946.
About California TMS Clinics California TMS Clinics, an affiliate clinic of LA Therapy Institute, is committed to unlocking the potential of human brain for patients suffering from mental health illnesses by providing innovative treatment intervention. This approach begins by using tools like advanced therapeutic interventions such as DBT, CBT, TMS, etc. to unravel the complexities of the human brain and understand the fundamentals of human psychology.
California TMS Clinics focuses on areas of high unmet psychological need and leverages its expertise to strive for solutions that improve mental health outcomes and dramatically improve people's lives. A professional psychology group since 2018, California TMS Clinics has grown to be one of the most reliable psychology clinics in Southern California. It has supported many patients developing coping to better manage their mental health challenge and reach their potential.
For more information, visit www.californiatmsclinics.com and follow us Instagram: @LATherapyInstitute
Contact: California TMS Clinics, Santa Monica
Dr. Soheila Hosseini, 310.490.0447 (Clinical Director)
Kyana Shajari, 310.857.4946 (Referral Coordinator)
1 - https://www.nimh.nih.gov/health/statistics/major-depression.shtml
2 - Per STAR*D patients that have failed one or more antidepressant trial of adequate dose and duration
3 - Sackeim HA, et al. (2020) J. Affect. Disord. Based on a real-world, retrospective study using CGI-S and a sample size of 615 patients.
4 - Janicak PG, et al. (2008) J. Clin. Psych